DNA methylation of HOXD3 as a marker of prostate cancer progression
- 1 July 2010
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 90 (7), 1060-1067
- https://doi.org/10.1038/labinvest.2010.57
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island MicroarraysPLOS ONE, 2009
- Integrating differentiation and cancer: The Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesisDifferentiation, 2008
- Role of homeobox genes in the patterning, specification, and differentiation of ectodermal appendages in mammalsJournal of Cellular Physiology, 2008
- Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assayProceedings of the National Academy of Sciences, 2007
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- Homeobox gene expression in cancer: Insights from developmental regulation and deregulationEuropean Journal Of Cancer, 2005
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Exploring the homeoboxGene, 1993